Quote this publication Share Print


Opinions on drugs - Posted on Jan 13 2011

Reason for request

Inclusion on list of products for hospital use.


Actual benefit


The actual benefit of ACTILYSE 2 mg is substantial.

Improvement in actual benefit

IV (mineur)

ACTILYSE 2 mg provides a minor improvement in actual benefit (IAB IV) in terms of efficacy in comparison with ACTOSOLV UROKINASE.

Contact Us

Évaluation des médicaments

See also

All our publication